Search: onr:"swepub:oai:DiVA.org:uu-282631" > PET-CT for staging ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05159naa a2200613 4500 | |
001 | oai:DiVA.org:uu-282631 | |
003 | SwePub | |
008 | 160406s2016 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:c59a5d62-0980-4441-854b-3771fa0a0bb7 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2826312 URI |
024 | 7 | a https://doi.org/10.1182/blood-2015-11-6794072 DOI |
024 | 7 | a https://lup.lub.lu.se/record/85925502 URI |
040 | a (SwePub)uud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Barrington, Sally Fu King's College London4 aut |
245 | 1 0 | a PET-CT for staging and early response :b results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. |
264 | 1 | b American Society of Hematology,c 2016 |
338 | a print2 rdacarrier | |
520 | a International guidelines recommend that positron emission tomography-computed tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this study were to compare PET-CT with CT for staging and measure agreement between expert and local readers, using a 5-point scale (Deauville criteria), to adapt treatment in a clinical trial: Response-Adapted Therapy in Advanced Hodgkin Lymphoma (RATHL). Patients were staged using clinical assessment, CT, and bone marrow biopsy (RATHL stage). PET-CT was performed at baseline (PET0) and after 2 chemotherapy cycles (PET2) in a response-adapted design. PET-CT was reported centrally by experts at 5 national core laboratories. Local readers optionally scored PET2 scans. The RATHL and PET-CT stages were compared. Agreement among experts and between expert and local readers was measured. RATHL and PET0 stage were concordant in 938 (80%) patients. PET-CT upstaged 159 (14%) and downstaged 74 (6%) patients. Upstaging by extranodal disease in bone marrow (92), lung (11), or multiple sites (12) on PET-CT accounted for most discrepancies. Follow-up of discrepant findings confirmed the PET characterization of lesions in the vast majority. Five patients were upstaged by marrow biopsy and 7 by contrast-enhanced CT in the bowel and/or liver or spleen. PET2 agreement among experts (140 scans) with a κ (95% confidence interval) of 0.84 (0.76-0.91) was very good and between experts and local readers (300 scans) at 0.77 (0.68-0.86) was good. These results confirm PET-CT as the modern standard for staging HL and that response assessment using Deauville criteria is robust, enabling translation of RATHL results into clinical practice. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
700 | 1 | a Kirkwood, Amy Au University College London4 aut |
700 | 1 | a Franceschetto, Antonellau University of Modena and Reggio Emilia4 aut |
700 | 1 | a Fulham, Michael Ju Royal Prince Alfred Hospital4 aut |
700 | 1 | a Roberts, Thomas Hu University College London4 aut |
700 | 1 | a Almquist, Helénu Lund University,Lunds universitet,Klinisk fysiologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Physiology (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)extLU-691 |
700 | 1 | a Brun, Evau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)onk-ebr |
700 | 1 | a Hjorthaug, Karinu Aarhus University Hospital4 aut |
700 | 1 | a Viney, Zaid Nu Guy's and St Thomas' NHS Foundation Trust4 aut |
700 | 1 | a Pike, Lucy Cu King's College London4 aut |
700 | 1 | a Federico, Massimou University of Modena and Reggio Emilia4 aut |
700 | 1 | a Luminari, Stefanou University of Modena and Reggio Emilia4 aut |
700 | 1 | a Radford, John4 aut |
700 | 1 | a Trotman, Judith4 aut |
700 | 1 | a Fosså, Alexander4 aut |
700 | 1 | a Berkahn, Leanne4 aut |
700 | 1 | a Molin, Danielu Uppsala universitet,Experimentell och klinisk onkologi4 aut0 (Swepub:uu)danimoli |
700 | 1 | a D'Amore, Francesco4 aut |
700 | 1 | a Sinclair, Donald A4 aut |
700 | 1 | a Smith, Paul4 aut |
700 | 1 | a O'Doherty, Michael J4 aut |
700 | 1 | a Stevens, Lindsey4 aut |
700 | 1 | a Johnson, Peter W4 aut |
710 | 2 | a King's College Londonb University College London4 org |
773 | 0 | t Bloodd : American Society of Hematologyg 127:12, s. 1531-1538q 127:12<1531-1538x 0006-4971x 1528-0020 |
856 | 4 | u https://kclpure.kcl.ac.uk/portal/files/51820460/Barrington_blood_2015_11_679407.full.pdf |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/26747247?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1182/blood-2015-11-679407y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-282631 |
856 | 4 8 | u https://doi.org/10.1182/blood-2015-11-679407 |
856 | 4 8 | u https://lup.lub.lu.se/record/8592550 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.